Spf 50 Moisturizing Sunscreen Broad Spectrum
NDC Package 72274-002-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Spf 50 Moisturizing Sunscreen Broad Spectrum is stop use and ask a doctor if rash occurs. Marketed by Gate Therapeutics, this product is identified by NDC 72274-002 and is authorized under FDA application part352.

Identification & Billing

NDC Package Code
72274-002-01
Package Description
30 mL in 1 TUBE
Product Code
11-Digit Billing Format
72274000201

Clinical Specifications

Proprietary Name
Spf 50 Moisturizing Sunscreen Broad Spectrum
Dosage Form
-
Usage Information
Stop use and ask a doctor if rash occurs

Regulatory & Marketing

Labeler Name
Gate Therapeutics
FDA Application #
part352
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
05-04-2018
Listing Expiration
12-31-2023
Exclude Flag
I
Sample Package
No

Hierarchy Structure

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (72274-002). Click a package code to view its specific billing and regulatory data.

90 mL in 1 TUBE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72274-002-01 identifies a specific commercial package of 30 ml in 1 tube of Spf 50 Moisturizing Sunscreen Broad Spectrum, labeled by Gate Therapeutics. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Gate Therapeutics on May 04, 2018. The current certification is valid through December 31, 2023.

How is this Gate Therapeutics product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72274000201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
72274-002-01
11-Digit CMS (5-4-2)
72274-0002-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.